Login | New Member? Signup Free
ChangeDetect » News

Tekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing Process and Mitigation of siRNA Immune

VANCOUVER, British Columbia — Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference therapeutics, announced today that the United States Patent & Trademark Office has recently issued two key patents: one covering its lipid nanoparticle manufacturing process and the other covering the chemical modification of siRNA to mitigate immune stimulation. (20 hours ago)

Tags: , , , , , , , , , , , , ,